Drug Type Biological products |
Synonyms- |
Target |
Mechanism p95HER2 agonists(HER2-p95 agonists) |
Therapeutic Areas- |
Active Indication- |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |